Edition:
United Kingdom

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

38.96USD
6:30pm GMT
Change (% chg)

$1.02 (+2.69%)
Prev Close
$37.94
Open
$37.23
Day's High
$39.24
Day's Low
$36.63
Volume
26,148
Avg. Vol
117,979
52-wk High
$69.23
52-wk Low
$18.45

Chart for

About

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38... (more)

Overall

Beta: --
Market Cap(Mil.): $731.75
Shares Outstanding(Mil.): 28.29
Dividend: --
Yield (%): --

Financials

  GTHX.OQ Industry Sector
P/E (TTM): -- 83.63 33.59
EPS (TTM): -1.88 -- --
ROI: -- -0.64 15.05
ROE: -- 0.08 16.62

Earnings vs. Estimates